Nippon Shinyaku Co., Ltd. (OTCMKTS:NPNKF – Get Free Report) was the target of a large growth in short interest in July. As of July 31st, there was short interest totaling 375,212 shares, a growth of 63.2% from the July 15th total of 229,961 shares. Based on an average trading volume of 117 shares, the short-interest ratio is presently 3,206.9 days.
Nippon Shinyaku Stock Performance
OTCMKTS:NPNKF opened at $23.50 on Wednesday. The firm has a 50-day simple moving average of $24.64 and a 200-day simple moving average of $30.52. Nippon Shinyaku has a one year low of $23.10 and a one year high of $32.00.
Nippon Shinyaku Company Profile
Nippon Shinyaku Co, Ltd. operates as a research-driven pharmaceutical company headquartered in Kyoto, Japan. It specializes in the discovery, development, manufacture and marketing of therapeutic drugs across multiple therapeutic areas, including urology, hematology, oncology and internal medicine. The company’s business model integrates in-house research capabilities with strategic collaborations to bring novel small-molecule and biologic products to market.
Established in 1909 by entrepreneur Yorisuke Tsuji, Nippon Shinyaku has evolved from a domestic manufacturer into a global healthcare enterprise.
Featured Stories
- Five stocks we like better than Nippon Shinyaku
- Speed Sells: Cerebras Cracks the Silicon Ceiling
- Amid Legal Risks, This Company Is Still Rated a Buy
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
Receive News & Ratings for Nippon Shinyaku Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nippon Shinyaku and related companies with MarketBeat.com's FREE daily email newsletter.
